BioNTech SE announced that Sean Marett, Chief Business and Commercial Officer, will retire as planned from the Management Board of BioNTech.
Market Closed -
Other stock markets
|
Pre-market 08:00:37 am | |||
90.61 USD | -2.55% | 92.03 | +1.57% |
May. 17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
May. 17 | Sector Update: Health Care Stocks Softer Friday Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.15% | 21.87B | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.77% | 21.96B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B | |
-24.95% | 8.23B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- BioNTech SE Announces Retirement of Sean Marett as Chief Business and Commercial Officer